FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:1522-1524 April 6, 2006 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Kyaw, M. H. PubMed Citation

A nationwide vaccination program may have direct or indirect health effects that may be anticipated or unanticipated; although these effects are, of course, intended to be beneficial, some potentially adverse ones may occur. The full range of such effects are well illustrated in the important study of the impact of widespread administration of the protein-conjugate pneumococcal vaccine PCV-7 (Prevnar, Wyeth) from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prevention, reported by Kyaw et al. in this issue of the Journal.¹

The most obvious direct effect of widespread vaccination of infants with protein-conjugated capsular polysaccharides . . . [Full Text of this Article]

Source Information

From the Medical Care Line (Infectious Disease Section), Michael E. DeBakey Veterans Affairs Medical Center, and the Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine — both in Houston.

This article has been cited by other articles:

• Adamkiewicz, T. V., Silk, B. J., Howgate, J., Baughman, W., Strayhorn, G., Sullivan, K., Farley, M. M. (2008). Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease in the First Decade of Life. Pediatrics 121: 562-569 [Abstract] [Full Text]  
• Kosowska-Shick, K., Clark, C., Credito, K., Dewasse, B., Beachel, L., Ednie, L., Appelbaum, P. C. (2008). In Vitro Capability of Faropenem To Select for Resistant Mutants of Streptococcus pneumoniae and Haemophilus influenzae. Antimicrob. Agents Chemother. 52: 748-752 [Abstract] [Full Text]  
• Clutterbuck, E. A., Oh, S., Hamaluba, M., Westcar, S., Beverley, P. C. L., Pollard, A. J. (2008). Serotype-Specific and Age-Dependent Generation of Pneumococcal Polysaccharide-Specific Memory B-Cell and Antibody Responses to Immunization with a Pneumococcal Conjugate Vaccine. CVI 15: 182-193 [Abstract] [Full Text]  
• Clark, C. L., Kosowska-Shick, K., Ednie, L. M., Appelbaum, P. C. (2007). Capability of 11 Antipneumococcal Antibiotics To Select for Resistance by Multistep and Single-Step Methodologies. Antimicrob. Agents Chemother. 51: 4196-4201 [Abstract] [Full Text]  
• Roche, A. M., King, S. J., Weiser, J. N. (2007). Live Attenuated Streptococcus pneumoniae Strains Induce Serotype-Independent Mucosal and Systemic Protection in Mice. Infect. Immun. 75: 2469-2475 [Abstract] [Full Text]  
• Poehling, K. A., Szilagyi, P. G., Grijalva, C. G., Martin, S. W., LaFleur, B., Mitchel, E., Barth, R. D., Nuorti, J. P., Griffin, M. R. (2007). Reduction of Frequent Otitis Media and Pressure-Equalizing Tube Insertions in Children After Introduction of Pneumococcal Conjugate Vaccine. Pediatrics 119: 707-715 [Abstract] [Full Text]  
• (2006). JOURNAL WATCH PEDIATRICS & ADOLESCENT MEDICINE. Arch. Dis. Child. 91: 712-713 [Full Text]  
• (2006). The Impact of Pneumococcal Conjugate Vaccine on Antibiotic-Resistant Disease. JWatch Pediatrics 2006: 6-6 [Full Text]  
• (2006). Herd Immunity Benefits of Pneumococcal Conjugate Vaccine. JWatch General 2006: 5-5 [Full Text]